Autoimmune liver disease
Conditions
Interventions
Control group:Basic treatment
Sponsors
The Fifth Medical Center of PLA General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria under 2.2 and do not meet the criteria of immunosuppressive therapy. 2. Patients aged between 18 and 75 years. 3. The patients voluntarily participated in the treatment, agreed to accept the treatment plan of Sancao formula granules, and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe complications of autoimmune hepatitis, such as decompensated cirrhosis, hepatic encephalopathy, liver failure, etc. 2. Patients with alcoholism or taking known hepatotoxic drugs. 3. Patients with severe allergic constitution cannot accept traditional Chinese medicine. 4. Patients who use other drugs that affect liver function and immune function before treatment. 5. Pregnant women, lactating women. 6. Patients with cardiac and renal insufficiency, patients with tumor, nervous system, hematopoietic system and other serious diseases, and patients with psychosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum biochemical indices (ALT, AST, ALP, GGT, TBIL);Serum immunoglobulin (IgG);TCM syndrome points; | — |
Countries
China
Contacts
Public ContactYanling Zhao
The Fifth Medical Center of PLA General Hospital
Outcome results
None listed